Nanosonosensitizers for Highly Efficient Sonodynamic Cancer Theranostics: Erratum

Ju Huang,Fengqiu Liu,Xiaoxia Han,Liang Zhang,Zhongqian Hu,Qinqin Jiang,Zhigang Wang,Haitao Ran,Dong Wang,Pan Li

DOI: https://doi.org/10.7150/thno.67168

IF: 11.6

2021-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.29569.].

medicine, research & experimental

What problem does this paper attempt to address?

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Jiaojiao Hao,Zhenglin Li,Changlin Zhang,Wendan Yu,Zhipeng Tang,Yixin Li,Xu Feng,Yue Gao,Quentin Liu,Wenlin Huang,Wei Guo,Wuguo Deng

DOI: https://doi.org/10.62347/suki5933

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].
Tumor Theranostics of Transition Metal Ions Loaded Polyaminopyrrole Nanoparticles: Erratum

Shuyao Li,Shuwei Liu,Lu Wang,Min Lin,Rui Ge,Xing Li,Xue Zhang,Yi Liu,Lening Zhang,Hongchen Sun,Hao Zhang,Bai Yang

DOI: https://doi.org/10.7150/ntno.67620

2022-01-01

Nanotheranostics

Abstract:[This corrects the article DOI: 10.7150/ntno.25119.].
Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Zekun Li,Yongchun Pan,Shiyu Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qin Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Corrigendum: Nano-sonosensitized Sonodynamic Nanomedicine Augments Tumor-Selective Catalytic Tumor Eradication

Haixian Zhang,Yiming Li,Junying Liu,Chang Cai

DOI: https://doi.org/10.3389/fmats.2022.1103132

2022-01-01

Frontiers in Materials

Abstract:• please read through all the templates before choosing • pick the most relevant text template(s) from the following page and delete all others.• edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated.In the published article, there was a mistake in the Funding statement.
Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Zekun Li,Yongchun Pan,Shizheng Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qiang Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Dual Target Gene Therapy to EML4-ALK NSCLC by a Gold Nanoshell-Based System: Erratum

Siwen Li,Yuxi Liu,Yalan Rui,Liping Tang,Samuel Achilefu,Yueqing Gu

DOI: https://doi.org/10.7150/thno.43075

IF: 11.6

2020-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.24469.].
Corrigendum to “the Induction of Reactive Oxygen Species and Loss of Mitochondrial Omi/HtrA2 is Associated with S-nitrosoglutathione-induced Apoptosis in Human Endothelial Cells” [toxicology and Applied Pharmacology 244 (2010) 374–384]

Qi-bing Liu,Lu-lu Liu,Ying-mei Lu,Rong-rong Tao,Ji-yun Huang,Feng Han,Yi-jia Lou

DOI: https://doi.org/10.1016/j.taap.2010.05.014

IF: 4.46

2010-01-01

Toxicology and Applied Pharmacology

Abstract:The listing of authors was incorrect in the published version. The correct author names and affiliations appear as above. The authors would like to include the following acknowledgments: We wish to thank Prof. K. Fukunaga (Tohoku University) for generously providing the antibodies (Nitrotyrosine, HtrA2, Fas, Fas ligand and TNFa). We also thank Dr. S. Moriguchi and N. Shioda (Tohoku University) for helpful comments and constructive discussion on the manuscript. Thisworkwas supported in part byNational Natural Science Foundations of China (30672564 to Y. Lou; 30973521 to F. Han), The Science Research Foundation of Chinese Ministry of Health (WKJ2009-2-029 to F. Han), The Key Foundation of Zhejiang Educational Committee (Z200803527 to F. Han) and by the Key Foundation of Modernization of Chinese Traditional Medicine of Zhejiang Province (2006C13075 to Y. Lou). The authors would like to apologize for any inconvenience caused.
Correction: Catalase-like Metal–organic Framework Nanoparticles to Enhance Radiotherapy in Hypoxic Cancer and Prevent Cancer Recurrence

Yuanyuan Chen,Hui Zhong,Jianbo Wang,Xiuyan Wan,Yanhua Li,Wei Pan,Na Li,Bo Tang

DOI: https://doi.org/10.1039/d0sc90108c

IF: 8.4

2020-01-01

Chemical Science

Abstract:Correction for ‘Catalase-like metal–organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence’ by Yuanyuan Chen et al., Chem. Sci., 2019, 10, 5773–5778, DOI: 10.1039/C9SC00747D.
Erratum to “Near-infrared responsive 5-fluorouracil and indocyanine green loaded MPEG-PCL nanoparticle integrated with dissolvable microneedle for skin cancer therapy” [Bioact. Mater. 5 (2020) 542–552]

Ying Hao,YuWen Chen,XinLong He,Fan Yang,RuXia Han,ChengLi Yang,Wei Li,ZhiYong Qian

DOI: https://doi.org/10.1016/j.bioactmat.2020.05.005

IF: 18.9

2021-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2020.04.002.].

engineering, biomedical,materials science, biomaterials
Correction: Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy

Huaxia Shi,Wucheng Sun,Changbing Liu,Guiying Gu,Bo Ma,Weili Si,Nina Fu,Qi Zhang,Wei Huang,Xiaochen Dong

DOI: https://doi.org/10.1039/d3tb90090h

IF: 7.571

2023-01-01

Journal of Materials Chemistry B

Abstract:Correction for ‘Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy’ by Huaxia Shi et al. , J. Mater. Chem. B , 2016, 4 , 113–120, https://doi.org/10.1039/C5TB02041G.

materials science, biomaterials
Preventing Tumor Progression to the Bone by Induced Tumor-Suppressing MSCs: Erratum

Xingming Sun,Kexin Li,Rongrong Zha,Shengzhi Liu,Fan Yang,Di Wu,Misato Hase,Uma K. Aryal,Chu‐Chieh Lin,Bai‐Yan Li,Hiroki Yokota

DOI: https://doi.org/10.7150/thno.77186

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.58779.].
Correction: A Highly Selective Dual-Therapeutic Nanosystem for Simultaneous Anticancer and Antiangiogenesis Therapy

Lizhen He,Yanyu Huang,Yanzhou Chang,Yun You,Hao Hu,Kam W. Leong,Tianfeng Chen

DOI: https://doi.org/10.1039/d0tb90089c

IF: 7.571

2020-01-01

Journal of Materials Chemistry B

Abstract:Correction for 'A highly selective dual-therapeutic nanosystem for simultaneous anticancer and antiangiogenesis therapy' by Lizhen He et al., J. Mater. Chem. B, 2017, 5, 8228-8237, DOI: 10.1039/C7TB02163A.
Erratum to "Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple-Negative Breast Cancer Treatment"

Hongye He,Feng Li,Rui Tang,Nianhong Wu,Ying Zhou,Yuting Cao,Can Wang,Li Wan,Yang Zhou,Hua Zhuang,Pan Li

DOI: https://doi.org/10.34133/bmr.0088

2024-10-07

Abstract:[This corrects the article DOI: 10.34133/bmr.0064.].
Erratum: Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled In Situ Accumulation: Erratum

Yujia You,Xiaolong Liang,Tinghui Yin,Min Chen,Chen Qiu,Chuang Gao,Xiaoyou Wang,Yongjiang Mao,Enze Qu,Zhifei Dai,Rongqin Zheng

DOI: https://doi.org/10.7150/thno.100601

IF: 11.6

2024-07-23

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.22469.].
Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles"

Kin Man Au,Rod Balhorn,Monique C Balhorn,Steven I Park,Andrew Z Wang

DOI: https://doi.org/10.1021/acscentsci.4c00703

2024-05-08

Abstract:[This corrects the article DOI: 10.1021/acscentsci.8b00746.].
Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Qi Chang Zheng,Shuai Jiang,Yu Zhe Wu,Dan Shang,Yong Zhang,Shao Bo Hu,Xiang Cheng,Chen Zhang,Ping Sun,Yang Gao,Zi Fang Song,Min Li

DOI: https://doi.org/10.3389/fbioe.2021.656268

IF: 5.7

2021-02-11

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2020.00512.].

multidisciplinary sciences
Correction: Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics.

Xinxin Liu,Zhongwen Yuan,Zheng Tang,Qi Chen,Jiarun Huang,Lizhen He,Tianfeng Chen

DOI: https://doi.org/10.1039/d2bm90091b

2022-01-01

Biomaterials Science

Abstract:Correction for 'Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics' by Xinxin Liu , , 2021, , 4691-4700, https://doi.org/10.1039/d1bm00348h.
Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway: Erratum

Hui-Juan Liu,Yuan Qin,Zi-Han Zhao,Yang Zhang,Jia-Huan Yang,Deng-Hui Zhai,Fang Cui,Ce Luo,Man-Xi Lu,Piao-Piao Liu,Heng-Wei Xu,Kun Li,Bo Sun,Shuang Chen,Hong-Gang Zhou,Cheng Yang,Tao Sun

DOI: https://doi.org/10.7150/thno.78949

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.46467.].

medicine, research & experimental
Erratum: Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway: Erratum.

Hui-Juan Liu,Yuan Qin,Zi-Han Zhao,Yang Zhang,Jia-Huan Yang,Deng-Hui Zhai,Fang Cui,Ce Luo,Man-Xi Lu,Piao-Piao Liu,Heng-Wei Xu,Kun Li,Bo Sun,Shuang Chen,Hong-Gang Zhou,Cheng Yang,Tao Sun

DOI: https://doi.org/10.7150/thno.78949

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.46467.].
Correction: Ce6-Conjugated and Polydopamine-Coated Gold Nanostars with Enhanced Photoacoustic Imaging and Photothermal/photodynamic Therapy to Inhibit Lung Metastasis of Breast Cancer.

Ziwei Li,Fan Yang,Di Wu,Yanhong Liu,Yang Gao,Haichen Lian,Hongxin Zhang,Zhibin Yin,Aiguo Wu,Leyong Zeng

DOI: https://doi.org/10.1039/d4nr90194k

IF: 6.7

2024-01-01

Nanoscale

Abstract:Correction for 'Ce6-Conjugated and polydopamine-coated gold nanostars with enhanced photoacoustic imaging and photothermal/photodynamic therapy to inhibit lung metastasis of breast cancer' by Ziwei Li et al., Nanoscale, 2020, 12, 22173-22184, https://doi.org/10.1039/D0NR05386D.

Nanosonosensitizers for Highly Efficient Sonodynamic Cancer Theranostics: Erratum

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Tumor Theranostics of Transition Metal Ions Loaded Polyaminopyrrole Nanoparticles: Erratum

Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Corrigendum: Nano-sonosensitized Sonodynamic Nanomedicine Augments Tumor-Selective Catalytic Tumor Eradication

Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Dual Target Gene Therapy to EML4-ALK NSCLC by a Gold Nanoshell-Based System: Erratum

Corrigendum to “the Induction of Reactive Oxygen Species and Loss of Mitochondrial Omi/HtrA2 is Associated with S-nitrosoglutathione-induced Apoptosis in Human Endothelial Cells” [toxicology and Applied Pharmacology 244 (2010) 374–384]

Correction: Catalase-like Metal–organic Framework Nanoparticles to Enhance Radiotherapy in Hypoxic Cancer and Prevent Cancer Recurrence

Erratum to “Near-infrared responsive 5-fluorouracil and indocyanine green loaded MPEG-PCL nanoparticle integrated with dissolvable microneedle for skin cancer therapy” [Bioact. Mater. 5 (2020) 542–552]

Correction: Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy

Preventing Tumor Progression to the Bone by Induced Tumor-Suppressing MSCs: Erratum

Correction: A Highly Selective Dual-Therapeutic Nanosystem for Simultaneous Anticancer and Antiangiogenesis Therapy

Erratum to "Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple-Negative Breast Cancer Treatment"

Erratum: Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled In Situ Accumulation: Erratum

Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles"

Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Correction: Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics.

Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway: Erratum

Erratum: Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway: Erratum.

Correction: Ce6-Conjugated and Polydopamine-Coated Gold Nanostars with Enhanced Photoacoustic Imaging and Photothermal/photodynamic Therapy to Inhibit Lung Metastasis of Breast Cancer.